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An inherited defect in the C3 convertase, C3b,Bb, associated with
glomerulonephritis. The control of the amplification C3 convertase,
C3b,Bb, of the serum complement system has been found to be
defective in five members of a family spanning three generations. One
of the five has membranoproliferative glomerulonephritis (MPGN) type
III and another has mild idiopathic rapidly progressive glomerulone-
phritis. The defect is manifested by low serum concentrations of C3 and
usually factor B with normal levels of the proteins which control the
convertase, H and I. C3 nephritic factor (C3NeF) was not demonstra-
ble. Enhanced C3 conversion was produced by the incubation of their
serum at 37°C for 30 mm. This conversion was further accelerated by
incubation after increasing the serum magnesium concentration by
increments ranging from 0.25 to 1.9 mt. Incremental additions of H to
serum depleted of H indicated that the amplification convertase of
affected family members required more H for its inhibition than did that
of normal subjects. This requirement was reduced by the addition of
purified normal C3 but not by the addition of purified C3 of the
propositus. It is postulated that affected family members are heterozy-
gous for a gene producing an abnormal C3 which, as a constituent of the
amplification convertase, C3b,Bb, confers resistance to H. Investiga-
tion of this apparently nephritogenic defect may provide insight into the
pathogenesis of these glomerulonephritides.
Deficit héréditaire de Ia C3 convertase, C3b,Bb, associé a une glomeru-
Ionephrite. Le contrôle de Ia convertase d'amplification de C3, C3b,Bb,
du complement sérique a été trouvé défectueux chez cinq membres
d'une famille couvrant trois generations. Un des cinq avait une glomer-
ulonéphrite membrano-proliférative (MPGN) de type III et un autre
avait une glomerulonephrite idiopathique rapidement progressive. Le
défaut se manifeste par des concentrations faibles de C3 et habituelle-
ment de facteur B seriques avec des niveaux normaux des protéines
contrOlant Ia convertase H et I. Le facteur néphritique C3 (C3NeF)
n'était pas démontrable. Une augmentation de Ia C3 conversion a été
produite par l'incubation de leur serum a 37°C pendant 30 mm. Cette
conversion était encore plus accélérée par incubation avec augmenta-
tion de Ia concentration de magnesium serique dans des valeurs
comprises entre 0,25 et 1,9 m. Des augmentations progressives d'H au
serum déplété en H ont montré que Ia convertase d'amplification des
membres de Ia famille touchée nécessitait plus d'H pour son inhibition
que cela était nécessaire aux sujets normaux. Ce besoin était réduit en
ajoutant du C3 normal puriflé, mais non du C3 puriflé des propositus. Ii
est postule que les membres des familles affectées sont héterozygotes
pour un gene produisant un C3 anormal, lequel, étant un constituant de
Ia convertase d'amplification C3b,Bb, confère une résistance a H.
L'investigation de ce défaut en apparence néphritogene pourrait fournir
des informations sur La pathogenie de ces glomerulonephrites.
cies of terminal complement components [51 with systemic
lupus erythematous (SLE) is well known and complete or
subtotal deficiency of C2 has been associated with membrano-
proliferative glomerulonephritis (MPGN) [6—10]. Recently, pa-
tients with partial deficiencies of complement components have
been reported to have immune complex disease. Glass et al [11]
found heterozygous C2 deficiency to be significantly more
frequent (5.1%) among patients with SLE than in the general
population (1.6%); low levels of C3 have been associated with
chronic glomerulonephritis. The low C3 levels have been the
result of heterozygous deficiency [12], a hypomorphic variant
of C3 (CM) [13] or secondary to partial H deficiency [14].
The present paper reports a family (the P family) with a
hitherto undescribed inherited defect of the complement system
in which two of the affected family members have relatively
rare forms of chronic glomerulonephritis. One sibling has
membranoproliferative glomerulonephritis (MPGN) type III
[151 and the other, idiopathic rapidly progressive glomerulone-
phritis [16]. Both children, as well as three other family
members, consistently have low serum concentrations of C3
and usually have low concentrations of factor B. Although their
C3 concentrations are in a range expected for heterozygous
deficiency of this protein, functional studies of their comple-
ment system give evidence of a defect in the regulation of the
amplification C3 convertase, C3b,Bb by the control protein, F!.
The presence of rare forms of chronic glomerulonephritis in two
of the five affected family members suggests that this defect is
nephritogenic.
Methods
Complement protein measurements. Studies were done on
serum from blood allowed to clot at room temperature or
plasma (citrate phosphate dextrose adenine), both stored at
—70°C. Measurements of Clq, C2, C4, C3, factor B, H, I, and
C4 binding protein (C4bp) were by radial immunodiffusion
(RID) [17, 181 using goat antiserum produced in this laboratory.
Ring diameters were measured with a lOx binocular micro-
Immune complex disease associated with deficiencies of
serum complement components is being reported with increas-
ing frequency. The association of homozygous C2 [1, 2] and C4
[3, 41 deficiencies and, occasionally, of homozygous deficien-
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scope with a reticule calibrated in millimeters in one eyepiece.
Measurements on serum specimens from 163 healthy hospital
personnel provided normal values.
Circjilating immune complexes (dC). CIC were measured by
a modification [19] of the solid phase Clq method of Hay,
Nineham, and Roitt [20]. Normal values were obtained from
serum specimens of 20 healthy hospital personnel.
Component minus regulatory protein levels (C—R). The
balance between the component and the regulatory proteins of
the C3b feedback mechanism was described previously [18].
This balance is expressed by C—R in which C is the sum of the
concentrations of the component proteins of the C3b feedback
mechanism, C3 and factor B, expressed as percent of the
average adult concentration, and R is the sum of the concentra-
tions of the regulatory proteins of that feedback, H and I,
expressed as a percent of the average concentration. The
calculation used the same average concentrations as used
previously [18]. Markedly negative values for C—R are seen
when complement reactive material is present in the
circulation.
Measurement of C3 conversion and factor B cleavage. In
functional studies of the complement system, C3 conversion
was quantitated by the loss of the B antigen of C3. This antigen
is present only on intact C3 and not on breakdown products
[21]. B antigen was measured by RID with antiserum made
monospecific for the B determinant by absorption with aged
serum. C3 conversion was expressed either as a percent of the
initial B antigen level or as the fall in B antigen concentration in
units per milliliter (U/mI).
Factor B cleavage was measured semiquantitatively by RID
using an antiserum containing antibody to Ba, the alpha migrat-
ing breakdown product of factor B, in a concentration relative
to that of other determinants, which resulted in the formation of
a double precipitin ring with serum containing cleaved factor B.
For the measurement, the area of the precipitin ring produced
by untreated serum, calculated from the ring diameter, was
subtracted from the area of the larger ring produced by the
serum after it had reacted with a complement activator.
d3 nephritic factor (C'3NeF. To test for C3NeF activity in
serum from affected members of the P family (P family serum),
the concentration of the B antigenic determinant of C3 was
measured before and after incubation for 20 mm at 37°C of a
mixture of equal volumes of serum from family members and
normal subjects.
Experiments with complement activators. The response of P
family serum to complement activators was tested by measure-
ment of C3 conversion and factor B cleavage. Zymosan was
suspended in 0.15 M NaCI, centrifuged and the pellet containing
0.1 mg suspended in 0.1 ml of serum. A precipitate of bovine
serum albumin (BSA-) antiBSA was prepared at equivalence
and 0.01 mg added to 0.1 ml of serum. To increase the serum
Mg level, small volumes of MgC1, solution, 0.005 to 0.04 M,
were added to 0.1 or 0.2 ml of serum. In all experiments,
experimental and control reaction mixtures were brought to the
same volume by the addition of 0.15 M NaCI. Samples for the
measurements were taken after the addition of the activator to
the serum cooled in ice and again after the serum was warmed
to 37°C. Incubation at 37°C with zymosan and immune precipi-
tate was for 5 mm and with Mgil for variable periods up to 30
mm.
Complement co,nponent isolation. H was isolated from nor-
mal human serum (NHS) containing 0.07 M EDTA and from
EDTA P family serum by passage of the serum over a column of
monospecific anti-H covalently coupled to Sepharose 4B [22].
The H was eluted with 3.5 M NaSCN and immediately dialyzed
against phosphate-buffered saline. The isolated protein was not
contaminated with other complement proteins as determined by
RID using antiserum to Clq, C2 through Co. P, factor B and I.
I was isolated by an identical procedure which used mono-
specific anti-I coupled to Sepharose 4B. The purified prepara-
tion contained I in high concentration but did not contain any of
the complement proteins listed above and it was devoid of H.
C3 was isolated from normal and P family plasma by the
method of Hammer et al [23]. After gel filtration on Sepharose
6B, the material was passed over a Sepharose 4B column to
which was linked antibody to IgG, IgA, 1gM, C4, CS, H, and
albumin. The final products showed precipitin lines represent-
ing only C3 when subjected to immunoelectrophoretic analysis
with goat antiserum to whole human serum. No precipitin rings
were seen when the preparations were tested by RID against
antisera to H, I, P, C4bp, Clq, C4, C2, CS, C6, C7, C8, C9. lgG,
IgA, 1gM, and albumin. The C3 preparations were homoge-
neous by sodium dodecyl sulfate polyacrylamide gel
electrophoresis.
Functional testing qf Ii and!. The EDTA NHS and EDTA P
family serum from which H was removed by immunoabsorp-
tion, as described above, were found, after concentration to the
original volume, to contain no H and were used as a reagent
(RH) for functional testing of H. The EDTA NHS and EDTA P
family serum used as a source of I was also found to be depleted
of that protein and was used as a reagent (RI) for functional
testing. By RID, the RH was found to contain I and the RI,H in
normal concentrations. Both contained the other alternative
pathway proteins in normal concentration but were devoid of
Clq. Some preparations were dialyzed to remove EDTA before
use. In all cases they were tested to determine the minimal
amount of Mg , as MgCI,, required to produce rapid C3
conversion and factor B cleavage. For functional tests of H or I,
tubes containing aliquots of the appropriate reagent were
cooled in an ice bath and increasing quantities of the missing
protein were added, followed by the minimal amount of Mg
determined as above. While in the ice bath, samples were
placed on RID plates for measurement of the B antigen of C3
and factor B cleavage. The tubes were then placed in a 37°C
water bath and after 20 mm the measurements were repeated.
Fig. 1. Pedigree of the P family. The diagonal lines through the symbols
indicate family members with low levels of C3 and factor B. The
propositus is indicated by the arrow. His brother, 111-2, also had
glomerulonephritis. Abbreviation: NT, not tested.
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Fig. 2. Silver impregnated electron micrograph of a glomerulus of the propositus (111-1). Abundant deposit material is seen in the capillary ioops oc-
cupying both subepithelial and subendothelial positions. There are numerous interruptions and duplications of lamina densa in relationship to the
deposits, characteristic of MPGN type III. (x5900)
Genetic polymorphism of C3. To determine C3 electrophoret-
ic variants, serum was subjected to high voltage electrophoresis
by the method of Teisberg [24J. Serum samples containing
known C3 variants, typed in the laboratory of Dr. Chester A.
Alper (Center for Blood Research, Children's Hospital Medical
Center, Boston, Massachusetts), were run concurrently with
samples from patients.
Statistical methods. The significance of differences of means
of small samples was calculated as described by Mainland [25].
Pedigree and clinical data
The pedigree of the P family is shown in Figure 1. The
propositus, 111-1, has MPGN type III. His brother, 111-2, has
mild idiopathic rapidly progressive glomerulonephritis.
111-1 (propositus). This male Caucasian was referred in 1968,
at age 12 years, with a history of hematuria and proteinuria of 2
years duration. Renal function was normal but the measure-
ment of complement proteins indicated low concentrations of
C3, CS, and P. Concentrations of Clq, C2, C4, factor B, H, I,
and C4bp, measured on serum specimens stored at —70°C, were
normal. By light microscopy, renal biopsy tissue showed
changes characteristic of MPGN type III [151 and by electron
microscopy, there were subendothelial and subepithelial depos-
its associated with a basement membrane which appeared
disrupted and replicated (Fig. 2). By immunofluorescence, C3
and P were present in large amounts along glomerular capillary
walls and IgG was found in deposits in proximity to the
capillary waist. Treatment was with prednisone given on alter-
nate days. A second renal biopsy 5 years later showed no
evidence of histologic progression (patient 6, [26]). Ten years
after diagnosis, the BUN was 22 mg/dl and the serum creati-
nine, 0.9 mg/dl. As shown in Table 1, in nine serum specimens
obtained over a 14-year period, concentrations of C3 were
consistently below the normal range. Concentrations of factor
B, on the other hand, were within the lower limit of the normal
range but the mean (15.4 mg/dl) was significantly lower than
that for 163 normal subjects (P < 0.001). Values for C-R were
markedly negative. In one specimen, Clq binding immune
complexes were in a slightly elevated concentration. Concen-
trations of I, H, C4bp, and C2 were normal.
111-2. The brother was referred in 1978, at age 6 years,
because of intermittent proteinuria in trace to 1 + amounts of
several years duration. He also had recurrent upper respiratory
infections. Serum C3 and factor B concentrations were low, but
-
-
—
I
752 Marder et a!
Table 1. Levels of complement proteins and circulating immune complexes in the serum of P family membersa
Normal range5 86to 169 13.3 to 31.5 2.4 to 4.9 37 to n8 61 to 116 1.9 to 3.6 * 35 <.8
Abbreviations: C-R, difference between sums of component and regulatory proteins of C3b amplification loop expressed as percent of normal
(see Methods and [181); CIC, circulating immune complexes.
a Abnormally low values are italicized.
Normal range ( 2 SD) for complement components are based on measurements on serum from 163 healthy hospital personnel.
other complement proteins were in normal concentration. A
renal biopsy specimen showed slight glomerular cellular prolif-.
eration with no adhesions or crescents. By immunofluores-
cence there were, however, numerous large mesangial deposits
containing C3, C5, and P but no Ig (Fig. 3). Electron microsco-
py showed large subepithelial deposits located along the nonfil-
tering portion of the basement membrane at the capillary waist.
The deposits were typical of those seen early in the course of
idiopathic rapidly progressive glomerulonephritis [16]. His pro-
teinuria disappeared without therapy, but 3 years later he had
an episode of gross hematuria followed by persistent microhe-
maturia and proteinuria. A second renal biopsy specimen
revealed the same abnormalities as the first. Urinalysis was
normal after 15 days of alternate day prednisone therapy. BUN
and serum creatinine concentrations were always within the
normal range. As shown in Table I, complement measurements
on 6 serum specimens obtained over a 3-year period have
consistently shown low concentrations of C3 and, usually,
factor B. The mean concentration of factor B was 11.1 mg/dl,
significantly (P < 0.001) less than the mean of controls. With
the exception of very negative C-R values, the concentrations
of the other proteins were well within the normal range.
As indicated in Figure 1, the grandfather, father, and sister of
the propositus also had persistently low serum concentrations
of C3 and factor B and low values for C—R. The grandfather, I-
1, had asthma and maturity onset diabetes but was not known to
have hematuria, proteinuria, or other signs of renal disease. He
died at age 70 of cardiac failure. The father and sister are in
good health and urinalyses have shown no abnormality.
The results of measurements of complement proteins in
serum specimens from these family members, as well as from
unaffected members, are shown in Table 1. The table indicates
Pedigree
no. Date
C3 Factor B I H
mgldl
C4bp C2
mgld!
C-R CIC
g/ml
142 1.81-1 06-27-78 6/ 12.4 4.8 67.6 2.9
1-2 06-27-78 155 26.9 5.3 68.8 1.9 23
Il-i 03-22-78
08-26-78
11-29-80
114
117
134
37
23
23
4.5
3.8
3.5
49.3
52.7
48
—
87
90
3.9
3.1
2.4
+ 56
+ 2
+ 26
11-2 06-19-78
06-27-78
08-26-78
11-29-80
59
61
54
74
10.5
9.6
/1.2
16
4.2
4.5
4.7
5.2
60.2
71.6
66.5
76
—
—
104
104
1.4
1.7
1.7
1.7
—125
—155
149
—142
11-4 08-26-78 106 24.2 4.3 56.2 3.1 26
111-1 01-29-68
06-10-68
11-05-71
04-23-73
11-06-76
05-14-77
08-26-78
06-09-80
05-10-82
20
24
44
33
44
51
46
47
58
14.5
20
15.6
18
15.6
14.6
14
/2
14.4
3.6
4.5
3.9
4.0
4.1
3.8
3.5
3.3
3.5
51.6
55
59.6
58.4
—
61.9
55
53
48
—
119
—
—
—
—
98
95
103
3.0
3.2
2.8
2.6
—
2.7
2.6
2.4
2.8
—104
—105
/03
101
—
—105
— 92
— 90
68
111-2 01-09-78
03-20-78
08-26-78
12-22-78
11-29-80
06-30-81
64
52
44
24
44
56
9.6
11.4
/0.6
12
7.3
16.4
3.4
3.7
3.5
3.7
2.8
4.5
56.1
54.4
52.7
51.0
46
57
—
—
87
100
82
115
2.4
2.9
2.6
3.8
2.1
2.7
97
—/02
—/03
— 9/
88
93
111-3 06-19-78
06-27-78
08-26-78
11-29-80
76
71
58
59
8.8
10.2
8.9
6.2
4.3
4.4
4.3
3.4
60
64.2
57.3
54
—
—
87
82
1.1
1.5
1.2
1.1
—
129
129
—1/2
111-4 09-28-78 128 24 3.9 56.1 96 2.9 -1- 1
111-5 08-26-78 109 21 3.8 2.6 — 7
19
10.3
1.4
8.0
Glomerulonephritis with a complement defect 753
Fig. 3. Immunofluorescence produced by
labeled antiserum to C3 in the glomerulus of
the brother of the propositus (111-2).
Numerous discrete deposits, some large, are
present which, by electron microscopy, were
subepithelial and at the capillary waist.
Table 2. Effect of complement activators in converting C3 in P family and normal serum. Incubation for 5 mm at 37°C
a Specimens from family members lI-i, 111-2, 111-3, and the propositus, Ill-I.
that concentrations of C2 were low in the father and the sister
and at the lower limit of normal in the grandmother. This
deficiency appears unrelated to the depressed C3 and factor B
concentrations.
Results
Tests for complement reactive material which might account
for the low C3 and factor B concentrations and the very
negative C—R values in P family serum yielded negative or
inconsistent results. C3NeF activity was not detectable. The
levels of CIC were slightly above the normal range in the
propositus and his father, who had no signs of renal disease, but
in other affected family members were well within the normal
range (Table 1). Levels of CIC measured by this method in
other patients with MPGN have varied widely [191.
The effect of incubation of P family serum with various
complement activators was extensively studied. In general, the
response differed from that of normal serum in that it was
accelerated. The results after a 5-mm incubation of the serum
with zymosan and BSA-anti BSA are shown in Table 2. Values
are given for the loss of B antigen both in units per milliliter and
as a percent of initial B antigen concentration. Expressed as
units per milliliter, B antigen loss with either activator in P
family serum was not significantly different from that of normal
serum. In fact, B antigen loss in undiluted NHS incubated with
BSA-anti BSA averaged significantly greater than in P family
serum. On the other hand, when B antigen loss was expressed
Serum source
No.
subjects
Average
initial
B antigen
pimi
Average B antigen loss
/2/mi P
Average B antigen loss
Percent
of initial P
BSA-anti BSA
Pfamilya 4 12.1 7.2 59.3
NHS 1:1 9 16.9 6.9 NS 40.8
NHS neat 9 36.8 12.0 < 0.01 32.5
Zymosan
P family° 4 12.7 6.7 51.9
NHS 1:1 9 17.3 4.6 NS 28.9
NHS neat 9 36.1 8.2 NS 22.8
< 0.01
< 0.01
< 0.01
< 0.01
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NHS NHS P
neat 1:1 family
Fig. 4. Effect of increasing the serum Mg concentration on C3
conversion in specimens of serum from nine normal subjects, undiluted
and diluted 1:1 and in serum from afJ'cted members of the P family.
Points for P family members are labeled with pedigree numbers; the
closed circles indicate family members with glomerulonephritis. C3
conversion is quantitated by the loss of the B antigen of C3 in units per
milliliter. The serum Mg concentration was increased by 1.5 m and
incubation was for 20 mm at 37°C. The horizontal lines indicate the
means and SCM.
as a percent of initial level rather than as units per milliliter, C3
conversion with both activators was significantly greater in P
family serum than in NHS. If the incubation was continued for
longer than 5 mm, B antigen loss in P family serum slowed and
the values equaled those of the control.
Incubation of P family serum after the addition of Mg
resulted in more marked C3 conversion than was seen with
other activators. Actual B antigen loss after the addition of
sufficient 0.04 M MgCl2 to raise the serum Mg concentration
by 1.5 m and incubating at 37°C for 20 mm is shown in Figure
4. Even expressed in units per milliliter, B antigen loss tended
to be greater in P tmily than in either undiluted or diluted
normal serum. Serum from family members without glomerulo-
nephritis responded similarly to specimens from those with
glomerulonephritis. Because the initial B antigen concentra-
tions in all of these specimens were lower than those in diluted
or undiluted NHS, B antigen loss expressed as a percent of
initial level was much greater in P family serum.
The results of another experiment in which the serum of the
propositus is incubated with various concentrations of Mg + is
shown in Figure 5. In this experiment, incubation at 37°C after
increasing the serum Mg* concentration by 1.92 m had no
effect on the C3 of normal serum hut lowered the concentration
of the B antigen of C3 by 85% in the serum of the propositus.
Although the percentage fall was less when less Mg was
added, it is noteworthy that even without adding Mg the B
antigen level in the serum of the propositus fell by 35% in 30
mm.
This response to complement activators suggested increased
formation or persistence of a C3 convertase. Persistence of the
amplification convertase, C3b.Bb, might be the result of a
defect in the proteins regulating this convertase, H or I.
Although both of these proteins were in normal concentration in
P family serum (Table 1) and had normal mobilities by immuno-
electrophoretic analysis, the possibility of a functional abnor-
mality arose. To test this possibility, I, isolated from the serum
of the propositus, was added back to a RI made from EDTA
NHS. As shown in Figure 6, without the addition of I, marked
cleavage of factor B occurred when Mg was added. In this
experiment, the amount of Mg added was sufficient to raise
the concentration in the reaction mixture by 0.68 m. Addition
of I before adding the Mg + inhibited factor B cleavage; normal
I and I isolated from serum of the propositus were equally
effective. Addition of Mg also caused conversion of about
50% of C3 and inhibition of this conversion by added I was
similar to the inhibition of factor B cleavage shown in Figure 6.
Both C3 conversion and factor B cleavage were markedly
inhibited at a concentration of either normal I or propositus I of
about 0.3 mg!dl, about 8% of physiologic concentration. Thus,
the I of the propositus was functionally normal.
The addition of Mg to an RH made from EDTA-NHS
resulted in C3 conversion of nearly 100% and moderate factor B
cleavage. Because the RH contained residual EIJTA, conver-
sion was seen only after the RH Mg concentration was
increased by 2.4 m by the addition of MgCI2. In several RH
preparations, H isolated from the serum of the propositus, from
the serum of the propositus' brother (111-2), and from NHS
were found to be equally effective in inhibiting C3 conversion
and factor B cleavage (data not shown); the concentrations
necessary for complete inhibition varied from 2 to 4 mgldl, 4 to
8% of the normal level, in the various experiments.
Experiments which were the reverse of the above were also
performed. Serum from the propositus, rather than NHS, was
depleted of I, or H, and small quantities of the missing protein
were added back. The results with propositus serum depleted of
I and with NHS depleted of I were essentially the same;
formation of C3b,Bb was similarly inhibited by increasing
concentrations of normal I. Very different results were obtained
with the RH. In two different RH preparations, one made from
serum of the propositus and the other from the serum of his
brother (111-2), a much higher concentration of H was required
12
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Fig. 5. B antigen concentration after the Mg concentration in normal
serum (circles) and serum from the propositus (squares) increased by
the amounts indicated and the serum incubated •for various time
intervals at 37°C.
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increased the effectiveness of H in controlling cleavage. The
results thus give no evidence of a defect in P family control
proteins H and I but indicate, instead, that the amplification
convertase, C3b,Bb, is resistant to control by H and that this is
a consequence of an abnormality in P family C3.
The defect in P family C3 could not be correlated with an
abnormal elecrophoretic mobility of this protein. Agarose gel
electrophoresis of serum from II-!, 11-2, 111-i, 111-2, and 111-3
indicated that all were phenotypically C3S.
Discussion
Combined heterozygous deficiency of C3 and factor B is
unlikely as the cause of the complement abnormality in the P
family since the structural genes for these two proteins are not
linked. The structural gene governing factor B polymorphism is
linked to HL-A [271 whereas that for C3 polymorphism is not
[28, 291.
The abnormal response of the P family complement system to
complement activators constitutes additional evidence against
heterozygous deficiency. With both alternative and classical
pathway activators there was a tendency for accelerated C3
conversion and factor B activation. The unequivocal accelera-
tion of C3 breakdown produced by incubation with Mg is a
response which would not be expected with complement defi-
ciency. It is well known that increasing the concentration of
Mg in serum causes, under certain circumstances, activation
of the alternative pathway with C3 conversion and factor B
cleavage [30, 31]. Kazatchkine, Fearon, and Austen [32] have
shown that increasing Mg + concentration increases the affini-
ty constant of factor B for C3b in a dose-dependent fashion
without alteration of the affinity of H for C3b.
The greater C3 conversion in P family serum in response to
an increased Mg concentration could be a consequence of a
greater content of the amplification C3 convertase, C3b,Bb.
Formation of this convertase is initiated by Mg dependent
binding of factor B to C3b to form C3b,B. Cleavage of the
bound factor B by D forms C3b,Bb and causes convertase
activity to be expressed. Under normal conditions in vivo, or in
serum in vitro, C3b is constantly being produced in small
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Fig. 7. Effect of H isolated from normal serum in inhibiting C3
conversion, expressed on the ordinate as in Figure 4, after the addition
of Mg to Iwo different EDTA RH preparations. The results in the RH
made from normal serum are indicated by the open circles and in an RH
made from the serum of propositus, by the solid circles.
Fig. 6. Effect of! in inhibiting factor B activation in an EDTA RI made
from NHS after reconstitution with The results with an I
isolated from normal serum are indicated by the open circles and for an
I isolated from the serum of the propositus, by the closed circles.
to prevent C3 conversion and factor B cleavage than was
required by an RH made from NHS. The data for C3 conversion
in the RH made from propositus serum are shown in Figures 7
and 8 and for factor B cleavage in Figure 9. The B antigen
concentration of NHS depleted of H was 37 U/ml and, with
incubation with Mg + alone, the concentration dropped to 1.2
U/ml, representing a C3 conversion of 35.8 U/ml or 97%. Thus,
in Figure 7 C3 conversion at zero H concentration is plotted as
35.8 U/ml. With the addition of increasing amounts of H to the
reaction mixture, C3 conversion diminished. Inhibition was
virtually complete at an H concentration of 3.5 mg/ml. In the
RH made from the serum of the propositus, the initial B antigen
concentration was 8 UIml, lower than for NHS, but again
virtually all of this B antigen disappeared on the addition of
MG. However, in this preparation, C3 conversion was not
prevented by the addition of even four times the amount of H
which prevented conversion in the RH made from normal
serum.
To assess the contribution of P family C3 to the unusual
requirement for H in this experiment, the C3 concentration of
the propositus RH was increased by adding to it C3 isolated
either from plasma of the propositus or normal human plasma.
The C3 of the propositus raised the B antigen concentration of
the propositus RH to 15.2 U/mI and the normal C3, to 21.8 U!
ml. As shown in Figure 8, the addition of normal C3 enhanced
the ability of H to inhibit C3 conversion as compared to the
effect of adding C3 of the propositus. Thus, at an H concentra-
tion of 12 mg/dl, 27% of the C3 was converted in an RH fortified
with normal C3 and 61% in an RH fortified with propositus C3.
As shown in Figure 9, data for factor B cleavage in these
experiments verified that H was relatively ineffective in control-
ling the amplification convertase in an RH made from serum
from the propositus. As with C3 conversion, inhibition of the
factor B cleavage in the propositus RH required a much higher
concentration of H than required for the normal serum RH.
This requirement was not reduced by fortifying the RH with C3
from the propositus whereas the addition of normal C3 greatly
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quantities by a "priming convertase," C3Bb, thought to be
assembled spontaneously by the interaction of C3, factor B and
D [33, 34]. From the spontaneously made C3b, C3b,Bb can be
formed which, by its convertase activity, creates more C3b.
C3b,Bb is thus a constituent of a positive feedback loop
normally controlled by the regulatory proteins. Part of this
regulation is the rapid inactivation of C3b,Bb by displacement
of Bb by H. Failure of inactivation of C3b,Bb would explain the
accelerated C3 conversion produced by incubation of serum
from the propositus at 37°C. The increase in C3 conversion
produced by the addition of Mg would be the result of
increased C3b,B, and hence C3b,Bb, formation.
C3NeF in P family serum would cause persistence of the
convertase activity of C3b,Bb, but it was not detectable. A
functional abnormality in H or I, proteins which regulate the
positive feedback, would reduce the rate of inactivation or
increase the rate of formation of C3b,Bb, but these proteins
were found to be functionally normal in that the concentrations
required to prevent feedback turnover were the same for the P
family proteins as for those isolated from NHS. Further experi-
ments indicated that the increased convertase activity was the
result of resistance of C3b,Bb to inactivation by H. This was
demonstrated by the experiments with EDTA RH made from
serum of the propositus or family member 111-2. When an RH is
reconstituted with C3b present in the serum forms with
factor B the Mgil dependent complex, C3bB, which becomes
an active convertase by cleavage of factor B by D, as noted
above. Because H is absent in this preparation, this convertase
activity of C3b,Bb is unopposed and through feedback cycling,
the C3b,Bb concentration rapidly rises and C3 conversion is
accelerated. As indicated in the present experiments, after
reconstitution of an RH made from normal serum with Mg,
concentrations of H which are 4 to 8% of the physiologic
concentration will inactivate C3b,Bb and prevent feedback
cycling. The fact that many times this amount of H is required
to control feedback cycling in a P family RH after reconstitution
with Mg gives evidence that the C3b,Bb formed is resistant
to inactivation by H. The fact that the H resistance persisted
when C3 from the propositus was added to the RH but was
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Fig. 9. Effeci of H isolated from normal serum in inhibiting factor B
cleavage, expressed as factor B precipitin ring expansion, after the
addition of Mg to various EDTA RH preparations. The results in an
RH made from normal serum are indicated by the open circles and in an
RH made from serum of the propositus, by the closed circles. Addition
of normal C3 to the propositus RH increased the effectiveness of H in
preventing factor B cleavage (open squares), but the addition of
propositus C3 had no effect (closed squares).
partially corrected by adding normal C3 (Figs. 7 to 9) gives
evidence that the defect is in C3. The resistance could be due to
the fact that C3, as C3b, has a lower affinity for H or has a
higher affinity for Bb, either of which would make H less
effective. The pattern of inheritence implies that affected family
members would be heterozygous for a gene producing this
abnormal protein. The low C3 and factor B levels and the very
negative C-R values would then be the result of spontaneous in
vivo formation of C3b,Bb containing the abnormal C3b. This
C3b,Bb would have an extended half-life because it would be
less susceptible to intrinsic, H-mediated decay but, presum-
ably, would still be susceptible to intrinsic decay.
The fact that both this complement abnormality and the
nephritides found in the propositus and his brother are rare
suggests a causal relationship. The basis for this relationship
cannot be stated with certainty. C3 is involved in many events
important in immune homeostasis including immune complex
attachment to phagocytes [35, 36], immune complex solubiliza-
tion [371, and modulation of the lymphocyte response to anti-
genie stimulation [38—40]. It is possible, for example, that the H
resistance of P family C3b,Bb might affect the ability of the
immune complexes bearing C3b to bind to phagocytes. Studies
of the cellular C3b receptor [41] have shown that, when
isolated, it reacts with C3b,Bb in a manner similar to H,
displacing Bb and acting as a cofactor in the inactivation of C3b
by I. Thus, if the P family defect was an abnormality of H
binding to the abnormal C3b and if this H binding site is the
same as that for the C3b receptor, affected family members
might handle complexes abnormally. Because some of the C3b
on the complexes would be unable to bind the C3b receptor,
their clearance from the circulation might be slowed. Like-
wise, methods for the detection of complexes, such as those
employing Raji cells, which depend on immobilization of com-
plexes by their attachment to a cellular C3b receptor, might give
spuriously low values and the optimum method would be one
depending on Clq binding. However, the solid phase Clq
method, as used in this study detected only slightly elevated
levels of complexes in the propositus and his father.
251
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Fig. 8. Effect of H isolated from normal serum in inhibiting C3
conversion after the addition of Mgil to an EDTA RH prepared from
3erum of the propositus to which either normal C3 (open squares) or
propositus 3 (closed squares) was added.
H in reaction mixture, mg/dI
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Alternatively, it is possible that a persistently low C3 concen-
tration in some way predisposes to glomerulonephritis. Pussell
et al [121 reported a patient with heterozygous C3 deficiency
and MPGN. A patient with chronic glomerulonephritis of
immune complex origin reported by McLean et a! [13] had an
intermittently low C3 concentration and was found to be
heterozygous for a hypomorphic variant of C3 (C31). Wyatt et al
[14] reported two families in which several members had low
serum levels of C3 and factor B secondary to a partial deficien-
cy of H. One of the family members had the hypocomplemente-
mic vasculitis syndrome, two had IgA nephropathy, and anoth-
er had hematuria and proteinuria of unknown origin. A survey
of patients with MPGN seen in this institution has shown that
an unusually high percentage has an inherited deficiency of one
or more complement components. Thus, it is possible that
persistently low levels of a component predispose to glomeru-
lonephritis regardless of the nature of the defect responsible for
the low level.
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